Tryptophanyl-tRNA Synthetase Sensitizes Hormone Receptor-Positive Breast Cancer to Docetaxel-Based Chemotherapy.
Kyung-Min LeeEun Hye HwangSeong Eun KangCheng Hyun LeeHyebin LeeHyeon Jeong OhKwang-Soo KimJiwon KohHan-Suk RyuPublished in: Journal of breast cancer (2020)
Our results suggest that WARS might be a potential predictor for chemotherapy response in patients with HR-positive breast cancer as well as a novel molecular target to improve chemosensitivity.